CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2025 Earnings Call Transcript August 8, 2025
Operator: Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics Second Quarter 2025 Financial Results Call. Please be advised that today’s call is being recorded. I would now like to hand the call over to your host for today, Chris Ogden, CytomX’ Chief Financial Officer. Please go ahead.
Christopher W. Ogden: Thank you. Good afternoon, and thank you for joining us. Before...
